JP2023518776A5 - - Google Patents

Info

Publication number
JP2023518776A5
JP2023518776A5 JP2022556477A JP2022556477A JP2023518776A5 JP 2023518776 A5 JP2023518776 A5 JP 2023518776A5 JP 2022556477 A JP2022556477 A JP 2022556477A JP 2022556477 A JP2022556477 A JP 2022556477A JP 2023518776 A5 JP2023518776 A5 JP 2023518776A5
Authority
JP
Japan
Prior art keywords
formula
compound
copper
salt
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022556477A
Other languages
English (en)
Japanese (ja)
Other versions
JP7761578B2 (ja
JP2023518776A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/083016 external-priority patent/WO2021190604A1/en
Publication of JP2023518776A publication Critical patent/JP2023518776A/ja
Publication of JP2023518776A5 publication Critical patent/JP2023518776A5/ja
Application granted granted Critical
Publication of JP7761578B2 publication Critical patent/JP7761578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556477A 2020-03-26 2021-03-25 シクロスポリン誘導体の調製 Active JP7761578B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2020081295 2020-03-26
CNPCT/CN2020/081295 2020-03-26
CNPCT/CN2021/078391 2021-03-01
CN2021078391 2021-03-01
PCT/CN2021/083016 WO2021190604A1 (en) 2020-03-26 2021-03-25 Preparation of cyclosporin derivatives

Publications (3)

Publication Number Publication Date
JP2023518776A JP2023518776A (ja) 2023-05-08
JP2023518776A5 true JP2023518776A5 (https=) 2024-04-05
JP7761578B2 JP7761578B2 (ja) 2025-10-28

Family

ID=77891510

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022556477A Active JP7761578B2 (ja) 2020-03-26 2021-03-25 シクロスポリン誘導体の調製
JP2022556478A Active JP7776435B2 (ja) 2020-03-26 2021-03-25 シクロフィリン阻害剤およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022556478A Active JP7776435B2 (ja) 2020-03-26 2021-03-25 シクロフィリン阻害剤およびその使用

Country Status (11)

Country Link
US (3) US20230174583A1 (https=)
EP (2) EP4126905A4 (https=)
JP (2) JP7761578B2 (https=)
KR (2) KR20220158761A (https=)
CN (2) CN115335389A (https=)
AU (1) AU2021240762A1 (https=)
BR (1) BR112022018929A2 (https=)
CA (2) CA3172601A1 (https=)
IL (1) IL296586B1 (https=)
MX (1) MX2022011697A (https=)
WO (2) WO2021190601A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111449050A (zh) * 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
AU2020363688A1 (en) 2019-10-12 2022-04-21 Farsight Medical Technology (Shanghai) Co., Ltd. Treatment and prevention of nephrotoxin-induced kidney injuries
IL296586B1 (en) * 2020-03-26 2026-04-01 Farsight Medical Tech Shanghai Co Ltd Cyclophilin inhibitors and their uses
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
GB202207348D0 (en) * 2022-05-19 2022-07-06 Cypralis Ltd Macrocyclic compounds and uses thereof
WO2024183651A1 (en) * 2023-03-03 2024-09-12 Farsight Medical Technology (Shanghai) Co., Ltd. Treatment and prevention of agent‐induced liver conditions or diseases
KR20260018851A (ko) * 2023-06-02 2026-02-09 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드 사이클로필린 저해제 및 그 용도

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
AU750245B2 (en) * 1997-10-08 2002-07-11 Aurinia Phamaceuticals Inc. Deuterated cyclosporine analogs and their use as immunomodulating agents
CN1205220C (zh) 1998-06-12 2005-06-08 斯-凯穆公司 新颖的环孢菌素
US6809077B2 (en) 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
CN100344648C (zh) 2001-10-19 2007-10-24 伊索泰克尼卡股份有限公司 环孢菌素类似物混合物及其在制备免疫调节剂中的用途
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
SI1802650T1 (sl) 2004-10-01 2012-03-30 Scynexis Inc Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c
ZA200703157B (en) * 2004-10-01 2008-08-27 Scynexis Inc 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
EP2023918B1 (en) * 2006-05-19 2011-03-23 Scynexis, Inc. Cyclosporins for the treatment and prevention of ocular disorders
WO2008143996A1 (en) * 2007-05-18 2008-11-27 Scynexis, Inc. New chemical processes
AU2009276241A1 (en) 2008-07-30 2010-02-04 Ciclofilin Pharmaceuticals Corp. Nonimmunosuppressive cyclosporine analogue molecules
KR20110111321A (ko) * 2009-01-30 2011-10-10 이난타 파마슈티칼스, 인코포레이티드 C형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
WO2011082289A1 (en) * 2009-12-30 2011-07-07 Scynexis Inc. Cyclosporine analogues
WO2012009715A2 (en) * 2010-07-16 2012-01-19 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
US9890198B2 (en) * 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
BR112013014890B1 (pt) 2010-12-15 2023-10-24 Contravir Pharmaceuticals, Inc Composto análogo de moléculas pertencentes à família ciclosporina, composição farmacêutica compreendendo o mesmo, uso terapêutico ou profilático do referido composto e processos para a preparação dos mesmos
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
US20140212381A1 (en) * 2012-10-19 2014-07-31 Scynexis, Inc. Macrocycles
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
GB201414806D0 (en) 2014-08-20 2014-10-01 Ucl Business Plc Cyclosporin conjugates
WO2017004304A1 (en) * 2015-06-30 2017-01-05 Cypralis Limited Novel macrocycles
CN106902346A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 药物组合物及其制药用途
CN106902347A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 亲环孢素抑制剂的用途
CN118324867A (zh) * 2016-05-17 2024-07-12 美国科技环球有限公司 新型环孢菌素衍生物及其用途
GB201711749D0 (en) * 2017-07-21 2017-09-06 Cypralis Ltd Cyclosporin analogues and uses thereof
WO2020037530A1 (en) * 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine
CN111449050A (zh) * 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
IL296586B1 (en) * 2020-03-26 2026-04-01 Farsight Medical Tech Shanghai Co Ltd Cyclophilin inhibitors and their uses

Similar Documents

Publication Publication Date Title
JP2023518776A5 (https=)
JP2022088416A5 (https=)
CN109678791B (zh) 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法
JP2018531218A5 (https=)
JP7761578B2 (ja) シクロスポリン誘導体の調製
JPS5946222B2 (ja) グアニジン化合物の製法
JP3140747B2 (ja) 新規il−1阻害剤の合成に有用なフランスルホンアミド化合物の能率的な製造方法
JP2022116171A5 (https=)
CN1188475A (zh) 胍衍生物,其中间体及其产物的制备方法
JP2010501617A5 (https=)
JP2006505567A5 (https=)
JP2016138105A5 (https=)
JP2001514619A (ja) 置換チアゾリジンジオンの製造方法
JP2004515542A (ja) キノロン類及びナフチリジン類の製造方法における環化工程
JP4577751B2 (ja) 芳香族ヘテロ環誘導体を含有するインテグラーゼ阻害剤
JP2005526073A5 (https=)
CN106188044A (zh) 一种碘催化的3‑芳硫基咪唑并[1,5‑a]N‑杂环化合物的合成方法
CN1533378A (zh) 制备喹唑啉的方法
CN113845509A (zh) 吲哚基取代螺[环丁烷-1,1′-茚]类化合物的合成方法
CN1930124A (zh) 制备交叉偶联吲哚的方法
JPWO2001017968A1 (ja) 芳香族ヘテロ環誘導体を含有するインテグラーゼ阻害剤
CN109912640B (zh) 一种2-吡咯烷酮类化合物的制备方法
JP2004525927A (ja) ランソプラゾール及びその中間体の製造方法
CN115315425A (zh) 一种取代的咪唑并[1,2-a]吡啶-2-基酰胺化合物的制备方法及其中间体
JPWO2021085535A5 (https=)